(Q40631524)

22 September 2017

title

Expression of hepatoma-derived growth factor in hepatocellular carcinoma (English)

1 reference

22 September 2017

Expression of hepatoma‐derived growth factor in hepatocellular carcinoma (English)

1 reference

14 March 2024

1 reference

14 March 2024

author name string

Tsung-Hui Hu

1

1 reference

22 September 2017

Chao-Cheng Huang

2

1 reference

22 September 2017

Li-Feng Liu

3

1 reference

22 September 2017

Pey-Ru Lin

4

1 reference

22 September 2017

Shang-Yun Liu

5

1 reference

22 September 2017

Hsueh-Wen Chang

6

1 reference

22 September 2017

Chi-Sin Changchien

7

1 reference

22 September 2017

Chuan-Mo Lee

8

1 reference

22 September 2017

Jiin-Haur Chuang

9

1 reference

22 September 2017

Ming Hong Tai

10

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

22 September 2017

number of pages

13

1 reference

full work available at URL

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11653

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11653

14 March 2024

1 reference

14 March 2024

1 reference

22 September 2017

volume

98

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

1444-1456

1 reference

Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Partial purification and characterization of human hepatoma-derived growth factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

An endothelial growth factor involved in rat renal development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Detection of a novel lactate dehydrogenase isozyme and an apparent differentiation-associated shift in isozyme profile in hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Review: assessment of cell proliferation in histological material

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépa

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11653

7 January 2021

Hepatocellular carcinoma: surgical treatment and prognostic variables in 56 patients

33

1 reference

Hyperplastic foci as a prognostic factor after resection of hepatocellular carcinoma

14 March 2024

34

1 reference

14 March 2024

Identifiers

DOI

10.1002/CNCR.11653

1 reference

22 September 2017

1 reference